Litcius/Paper detail

Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy

Charles C. Wykoff, Muneeswar Gupta Nittala, Cecilia Villanueva Boone, Hannah J. Yu, Wenying Fan, Swetha Bindu Velaga, Justis P. Ehlers, Michael S. Ip, SriniVas R. Sadda, Charles C. Wykoff, Muneeswar G. Nittala, Cecilia Villanueva Boone, Hannah J. Yu, Brenda Zhou, Wenying Fan, Swetha Bindu Velaga, Alexander M. Rusakevich, Shaun I.R. Lampen, Michael S. Ip, SriniVas R. Sadda, Justis P. Ehlers, Sunil K. Srivastava, Jamie L. Reese, Amy Babiuch, Katherine Talcott, Natalia Figueiredo, Sari Yordi, Jenna Hach, William C. Ou, Richard H. Fish, Matthew S. Benz, Eric Chen, Rosa Y. Kim, James C. Major, Ronan E. O’Malley, David M. Brown, Ankoor R. Shah, Amy C. Schefler, Tien P. Wong, Christopher R. Henry, Sagar B. Patel, Vy T. Nguyen, Kelly L. Larkin

2022Ophthalmology Retina15 citationsDOI

Topics & Concepts

AfliberceptMedicineDiabetic retinopathyOphthalmologyDosingRandomized controlled trialVisual acuityRanibizumabAdverse effectRetinalConfidence intervalInternal medicineBevacizumabDiabetes mellitusChemotherapyEndocrinologyRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Imaging and Analysis